Tissue sealant compositions, vascular closure devices, and uses thereof
The present invention provides tissue sealant compositions and vasculature closure devices useful for the optical detection of tissue seal and/or clot formation. Compositions and devices of the present invention comprise optical dyes which undergo an observable change as the compositions and/or devices are incorporated into a tissue seal and/or clot, for example a change in fluorescence quantum yield and/or a change in visual color including a change in emission and/or absorption wavelength. Tissue sealants and vasculature closure devices of the present invention are useful for visualizing seal and/or clot formation, for example, during or after surgical procedures, after catheter removal, etc. The present invention further provides methods for formation and optical detection of tissue seals or vasculature puncture closures as well as medical kits useful for the formation and optical detection of tissue seals or vasculature puncture closures.
1. A method for at least partially occluding an opening in a vascular tissue using vascular closure device, wherein said device comprises:
a plug or an adhesive material for at least partially occluding an opening in a vasculature tissue; and
an optical dye covalently bound to, or noncovalently associated with, the plug or adhesive material;
and wherein the method comprises the steps of activating the plug or adhesive material resulting in the formation of a seal between the vasculature tissue and the plug or adhesive material by reacting with substances naturally present in blood or the vasculature tissue; and
incorporating the optical dye into said seal, or into a clot, fibrin network or synthetic polymer network in the at least partially occluded opening in the vasculature tissue;
wherein said seal between the vasculature tissue and the plug or adhesive material at least partially occludes the opening in the vasculature tissue; and
wherein the optical dye exhibits a first optical condition when the plug or adhesive material is in a first state prior to forming said seal between the vasculature tissue and the plug or adhesive material and exhibits a second optical condition that is distinguishable from the first optical condition when the plug or adhesive material is in a second state after forming said seal between the vasculature tissue and the plug or adhesive material; and
wherein a change from the first optical condition to the second optical condition of the optical dye is caused by incorporation of the optical dye into said seal, or into a clot, fibrin network or synthetic polymer network in the at least partially occluded opening in the vasculature tissue.
2. The method of claim 1 , wherein at least partial occluding of the opening in the vasculature tissue initiates a coagulation cascade in a subject.
3. The method of claim 1 , wherein the formation of the seal between the vasculature tissue and the plug or adhesive material, a fibrin network, a synthetic polymer network or a clot occludes the opening in a vasculature tissue.
4. The method of claim 1 , wherein the optical condition is absorbance, fluorescence, color, reflectance or an optoacoustic condition.
5. The method of claim 1 , wherein the first optical condition of the optical dye is a first fluorescence quantum yield prior to at least partially occluding the opening in the vasculature tissue and the second optical condition of the optical dye is a second fluorescence quantum yield after at least partially occluding the opening in the vasculature tissue, wherein the second fluorescence quantum yield is different from the first fluorescence quantum yield; wherein the first fluorescence quantum yield is substantially equal to 0 and the second fluorescence quantum yield is greater than or equal to 0.01, or wherein the second fluorescence quantum yield is greater than the first fluorescence quantum yield by at least a factor of 1.5 or is less than the first fluorescence quantum yield by at least a factor of 1.5.
6. The method of claim 1 , wherein the first optical condition of the optical dye is a first emission wavelength or distribution of emission wavelengths prior to at least partially occluding the opening in the vasculature tissue and the second optical condition of the optical dye is a second emission wavelength or distribution of emission wavelengths after at least partially occluding the opening in the vasculature tissue, wherein the second emission wavelength or distribution of emission wavelengths is different from the first emission wavelength or distribution of emission wavelengths; wherein the second emission wavelength is greater than or less than the first emission wavelength by at least 20 nanometers, or wherein at least a portion of the second distribution of emission wavelengths is greater than or less than at least a portion of the first distribution of emission wavelengths by at least 20 nanometers.
7. The method of claim 1 , wherein the first optical condition of the optical dye is a first absorption wavelength corresponding to an absorption maximum in the visible or near infrared regions of the electromagnetic spectrum prior to activation of the adhesive material and the second optical condition of the optical dye is a second absorption wavelength corresponding to an absorption maximum in the visible or near infrared regions of the electromagnetic spectrum after activation of the adhesive material, wherein the second absorption wavelength is different from the first absorption wavelength; wherein the second absorption wavelength is greater than the first absorption wavelength by at least 20 nanometers or wherein the second absorption wavelength is less than the first absorption wavelength by at least 20 nanometers.
8. The method of claim 1 , wherein the plug or adhesive material comprises at least one component selected from the group consisting of coagulation factor, a platelet factor, a coagulation activator, a platelet activator, a vasoconstrictor, a fibrinolysis inhibitor, a glycosaminoglycan, a polysaccharide, a growth factor, a biopolymer, or a dendrimer.
9. The method of claim 1 , wherein the plug or adhesive material comprises collagen, fibrin, fibrinogen, fibronectin, prothrombin, thrombin, thromboplastin, factor V, factor X, or factor XIII.
10. The method of claim 1 , wherein the optical dye comprises a group corresponding to a pyrazine, a thiazole, a phenylxanthene, a phenothiazine, a phenoselenazine, a cyanine, an indocyanine, a squaraine, a dipyrrolo pyrimidone, an anthraquinone, a tetracene, a quinoline, an acridine, an acridone, a phenanthridine, an azo dye, a rhodamine, a phenoxazine, an azulene, an azaazulene, a triphenyl methane dye, an indole, a benzoindole, an indocarbocyanine, a Nile Red dye, a thionin dye, an isosulfan blue dye, or a benzoindocarbocyanine.
11. The method of claim 1 , wherein said substances naturally present in the blood or vasculature tissue are a part of the coagulation or clotting process.
12. A method of using a vascular closure device comprising:
a plug or an adhesive material for at least partially occluding an opening in a vasculature tissue; and
an optical dye covalently bound to, or noncovalently associated with, the plug or adhesive material;
wherein the method comprises the steps of activating the plug or adhesive material to form a seal between the vasculature tissue and the plug or adhesive material by electromagnetic radiation; and
incorporating the optical dye into said seal, or into a clot, fibrin network or synthetic polymer network in the at least partially occluded opening in the vasculature tissue;
wherein said seal between the vasculature tissue and the plug or adhesive material at least partially occludes the opening in the vasculature tissue; and
wherein the optical dye exhibits a first optical condition when the plug or adhesive material is in a first state prior to forming said seal between the vasculature tissue and the plug or adhesive material and exhibits a second optical condition that is distinguishable from the first optical condition when the plug or adhesive material is in a second state after forming said seal between the vasculature tissue and the plug or adhesive material; and
wherein a change from the first optical condition to the second optical condition of the optical dye is caused by incorporation of the optical dye into said seal, or into a clot, fibrin network or synthetic polymer network in the at least partially occluded opening in the vasculature tissue.